- Renazol drug is responsible for blocking the activity of H + / K + ATPase (ie. The proton pump). It decreases the production of hydrochloric acid and reduces the symptoms associated with the presence of hyperacidity.
Each capsule contains 15 mg of lansoprazole. Other excipients are: sucrose - granules, sodium lauryl sulfate, mannitol, meglumine, hypromellose, macrogol 6000, talc, polysorbate 80, titanium dioxide (E171), methacrylic acid-ethyl acrylate copolymer (1: 1). The composition of the capsule shell: quinoline yellow (E104), titanium dioxide (E171), gelatin, purified water.
Renazol a drug acting on the basis of lansoprazole, which is responsible for blocking the enzyme-producing gastric acid. Thus effectively reduces the amount of acid in the stomach, and clearly reduces irritating impact of acid reflux, among others, the esophagus. The first effects of the preparation can be observed after about 1-2 hours of application and lasts for at least a day. Renazol in the form of capsules for oral use.
- Hypersensitivity to the active components of the preparation
- pregnancy and lactation
- concomitant use of atazanavir
- use in patients under 18 years of age
Use in adults as part of short-term treatment of symptoms of gastroesophageal reflux disease (accompanied by heartburn and acid reflux of gastric contents), as well as gastric and duodenal ulcers and Zollinger-Ellison syndrome.
For oral use. Duodenal ulcers use of 30 mg (two 15 mg capsules) x 1 / 24h for 2 weeks (with gastric ulcers and reflux for 4 weeks). If needed, extend the treatment for another 14 days (gastric ulcers and reflux for 28 days).